RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.44

EPS Forecast

$178.2

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
CRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncREPLReplimune Group IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna IncDNLIDenali Therapeutics Inc